FindTrial
Sign In

brostallicin

DRUG5 trials

Sponsors

European Organisation for Research and Treatment of Cancer - EORTC, Case Comprehensive Cancer Center, Systems Medicine LLC, Alliance for Clinical Trials in Oncology

Conditions

Gastrointestinal Stromal TumorMultiple Myeloma and Plasma Cell NeoplasmMyxoid LiposarcomaOvarian CancerSarcomaSmall Intestine CancerTriple-negative Breast Cancer

Phase 1

Brostallicin in Treating Patients With Recurrent or Refractory Multiple Myeloma
CompletedNCT00060203
Case Comprehensive Cancer CenterMultiple Myeloma and Plasma Cell Neoplasm
Start: 2002-12-31End: 2004-04-30Updated: 2014-01-16

Phase 2

Brostallicin in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma
CompletedNCT00041249
European Organisation for Research and Treatment of Cancer - EORTCGastrointestinal Stromal Tumor, Sarcoma
Start: 2002-05-31Updated: 2012-07-18
Brostallicin or Doxorubicin as First-Line Therapy in Treating Patients With Relapsed, Refractory, or Metastatic Soft Tissue Sarcoma
NCT00410462
European Organisation for Research and Treatment of Cancer - EORTCOvarian Cancer, Sarcoma, Small Intestine Cancer
Start: 2006-10-31Updated: 2014-08-08
Brostallicin Clinical Trial for Myxoid Liposarcoma
NCT00633165
Systems Medicine LLCMyxoid Liposarcoma
Start: 2007-08-31End: 2010-06-30Target: 24Updated: 2010-02-26
Brostallicin and Cisplatin in Treating Patients With Metastatic Breast Cancer
CompletedNCT01091454
Alliance for Clinical Trials in OncologyTriple-negative Breast Cancer
Start: 2010-06-30End: 2014-11-01Updated: 2018-05-08